Clinical Trials Reporting by Sex, Race, and Ethnicity Signed into Law
Society for Women's Health Research (SWHR)President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9. This Act reauthorizes FDA’s user fee program, which is critical to the Agency’s funding, and also includes a provision that has been long sought by the Society for Women’s Health Research (SWHR), the American Heart Association (AHA) and Women Heart: The National Coalition for Women with Heart Disease (WomenHeart) that will require FDA to provide a special report and accounting of trials by sex, race, and ethnicity.